All results
1 results for tests
-
REMODEL II
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS) The study CLOU064C12302 consists of…
- Ages
- 18 Years - 55 Years
- Sexes
- All